Related Experiment Video
Updated: May 9, 2026

09:17
Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
21.6K
Accuracy of Integrated Artificial Intelligence Grading Using Handheld Retinal Imaging in a Community Diabetic Eye
Recivall P Salongcay1,2,3, Lizzie Anne C Aquino2, Glenn P Alog2,3
1Centre for Public Health, Queen's University Belfast, Belfast, United Kingdom.
Ophthalmology Science
|February 6, 2024
Summary
Point-of-care artificial intelligence (AI) shows good performance in identifying referable diabetic retinopathy (DR), meeting FDA thresholds. While not meeting thresholds for vision-threatening DR, AI integration could speed up patient referrals and reduce workload.
Area of Science:
- Ophthalmology
- Medical Imaging
- Artificial Intelligence
Background:
- Diabetic retinopathy (DR) and diabetic macular edema (DME) are leading causes of vision loss in diabetic patients.
- Early detection and management are crucial to prevent vision-threatening complications.
- Current screening methods often rely on centralized reading centers (RCs), which can cause delays in diagnosis and treatment.
Purpose of the Study:
- To evaluate the performance of point-of-care (POC) artificial intelligence (AI) in identifying diabetic retinopathy (DR) and diabetic macular edema (DME) using handheld retinal images.
- To compare POC AI assessment with traditional retinal image grading by RCs.
Main Methods:
- A prospective, comparative study involving 5,585 eyes from 2,793 adult patients with diabetes.
- Handheld retinal images were assessed by POC AI and compared with 5-field RC evaluation.
- Sensitivity and specificity for referable DR (refDR) and vision-threatening DR (vtDR) were calculated.
Main Results:
- Substantial agreement was found between AI and RC for refDR (κ=0.66) and moderate agreement for vtDR (κ=0.54).
- POC AI achieved a sensitivity of 0.86 and specificity of 0.86 for refDR, meeting FDA thresholds.
- POC AI had a sensitivity of 0.92 and specificity of 0.80 for vtDR, not meeting FDA thresholds.
- Image ungradable rates were 7.5% by RC and 15.4% by AI.
Conclusions:
- POC AI demonstrates capability in identifying refDR, meeting FDA standards, potentially improving screening efficiency.
- While not meeting thresholds for vtDR, POC AI integration can reduce RC burden and expedite patient care.
- Implementing POC AI could lead to faster information delivery and more prompt eye care referrals for diabetic patients.

